Published Date : 25 Sep 19 | Views: 165 | Industry : Life Science
Breast cancer segment to show impressive growth in the
global Paclitaxel market
The global
Paclitaxel market is segmented into two segments such as by product and by
application. By product, the market is further segmented into natural
Paclitaxel API and semi-synthetic Paclitaxel API. Where API stands for Active
Pharmaceutical Ingredient.
By application,
the market is segmented into cervical cancer, ovarian cancer, breast cancer,
and Others. It has been observed the increasing number of breast cancer
patients across the globe and Paclitaxel is a chemotherapy medication used to
treat cancer, which is projected to notice high demand during the predicted
period. Various pharmaceutical companies are innovating drugs with lesser side
effects and high results especially for women who are suffering from breast
cancer.
Rising health awareness in North America could boost
the demand for Paclitaxel
North America is
expected to account for a prominent share in the global Paclitaxel market. In
North America, advanced technologies, rising health awareness, and expenditure
towards the treatment are increasing the demand for Paclitaxel during the
predicted period. Apart from North America, Asia Pacific is also anticipated to
measure a heavy growth in the global Paclitaxel market because of research and
development activities and the growing number of healthcare centers.
Some of the
leading market participants operating in the global Paclitaxel market are
ScinoPharm, TAPI (Teva), Southpharma, Samyang, Huiang biopharma, Hainan Yew
Pharm, Yunnan Hande, Novasep, Fresenius, Jiangsu, Polymed, Phyton, and kabi.
Key players are incorporating various strategies such as collaboration, mergers
and acquisitions, and product differentiation in order to foothold the global
market.
High occurrence of cancer cases to drive the global
Paclitaxel market
Paclitaxel is
used for the treatment of various types of cancers for positive results, this
could be one of the driving factors increasing the demand for Paclitaxel in the
global market. The Paclitaxel displays immediate positive results. Changing
lifestyles, work pressure, unhealthy diet, and pollution are some of the
elements which could higher the risk of cancer.
High incidences of cancer all over the world is foreshown to accelerate the overall market growth. Paclitaxel is easily available and there is a continuous drug development, which is likely to increase the demand for Paclitaxel in the upcoming years. However, a disproportionate injection of the drug can cause various side effects such as skin diseases, weight loss, infections, diarrhea, and several other diseases are prophesied to hamper the market growth.